Home » Stocks » HOLX

Hologic, Inc. (HOLX)

Stock Price: $71.97 USD -2.85 (-3.81%)
Updated Mar 3, 2021 4:00 PM EST - Market closed
Market Cap 18.55B
Revenue (ttm) 4.54B
Net Income (ttm) 1.38B
Shares Out 258.61M
EPS (ttm) 5.27
PE Ratio 13.67
Forward PE 8.59
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $71.97
Previous Close $74.82
Change ($) -2.85
Change (%) -3.81%
Day's Open 74.60
Day's Range 71.72 - 75.05
Day's Volume 1,372,696
52-Week Range 26.49 - 85.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 day ago

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 1 day ago

Hologic (HOLX) strengthens international capabilities and expands diagnostics arm across test menu, customer segments and geography with recent acquisition.

Business Wire - 2 days ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #acquisition--Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million

Business Wire - 1 week ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

Zacks Investment Research - 1 week ago

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Other stocks mentioned: BSX, COO, LH, MASI, MDT, XRAY
Zacks Investment Research - 1 week ago

Investors continue to be optimistic about Hologic (HOLX) due to a slew of product launches.

Zacks Investment Research - 2 weeks ago

Hologic (HOLX) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research - 2 weeks ago

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 2 weeks ago

Top Ranked Growth Stocks to Buy for February 11th

Other stocks mentioned: APAM, CWH, MDC
Business Wire - 3 weeks ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #holx--Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences

Zacks Investment Research - 3 weeks ago

Top Ranked Growth Stocks to Buy for February 9th

Other stocks mentioned: ARCB, CLS, KBH
Zacks Investment Research - 3 weeks ago

Skyworks (SWKS), Hologic (HOLX), II-VI (IIVI) and MaxLinear (MXL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Other stocks mentioned: IIVI, MXL, SWKS
OTC PR Wire - 3 weeks ago

Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many year...

Other stocks mentioned: ALST, FLGT
Zacks Investment Research - 3 weeks ago

Does Hologic (HOLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 3 weeks ago

At this stage, it will be prudent to invest in growth stocks with a favorable Zacks Rank. These are: AAPl, F, FDX, HOLX, WY.

Other stocks mentioned: AAPL, F, FDX, WY
Zacks Investment Research - 3 weeks ago

DCP Midstream (DCP), TEGNA (TGNA), Hologic (HOLX), Crocs (CROX) and Skyworks Solutions (SWKS) are five stocks with explosive relative price strength.

Other stocks mentioned: CROX, DCP, SWKS, TGNA
Business Wire - 3 weeks ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #ESG--Hologic's New Sustainability Report Highlights How the Company's Purpose-Driven Culture is Making a Unique Difference in the World

CNBC Television - 1 month ago

Hologic CEO says Covid-19 testing ramp up has given the company a leg up for future business

Steve Macmillan, chief executive of the diagnostic equipment manufacturer, explained why the business trajectory for Hologic will be even stronger for the company post pandemic.

CNBC - 1 month ago

"We've clearly gotten a big bump up from our Covid testing," Hologic CEO Steve Macmillan said in a "Mad Money" interview.

Zacks Investment Research - 1 month ago

From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.

Other stocks mentioned: AVXL, AXSM, MRNA, NVAX, SAVA, VIVO, VXRT
Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for February 3rd

Other stocks mentioned: LL, MTSI, VALE
Zacks Investment Research - 1 month ago

Solid Companies for Investors Interested in Medical Stocks and Big Boats.

Other stocks mentioned: HZO
Business Wire - 1 month ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #AI--Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for February 1st

Other stocks mentioned: APAM, KBH
Zacks Investment Research - 1 month ago

Is (HOLX) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 month ago

Hologic (HOLX) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 1 month ago

Hologic (HOLX) exhibited robust segmental growth in first-quarter fiscal 2021, driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.

Zacks Investment Research - 1 month ago

At this stage, it will be prudent to invest in large-cap stocks that have strong growth potential for 2021. These are: FDX, F, HOLX, MOS and LEN.

Other stocks mentioned: F, FDX, LEN, MOS
Seeking Alpha - 1 month ago

Hologic, Inc. (HOLX) CEO Steve MacMillan on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 1 month ago

Hologic (HOLX) delivered earnings and revenue surprises of 33.64% and 0.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 month ago

Shares of Hologic (NASDAQ:HOLX) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 368.85% year over year to $2.86, which b...

Business Wire - 1 month ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #earnings--Hologic Announces Financial Results for First Quarter of Fiscal 2021

Zacks Investment Research - 1 month ago

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for January 27th

Other stocks mentioned: AMX, HIBB, PKI
Zacks Investment Research - 1 month ago

Hologic (HOLX) aims to optimize, simplify and streamline hysteroscopic workflow with the latest European launch of its fluid management system.

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for January 21st

Other stocks mentioned: GPK, PHM, PKI
Zacks Investment Research - 1 month ago

Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the first quarter of fiscal 2021 amid the coronavirus-led economic doldrums.

Zacks Investment Research - 1 month ago

In the latest trading session, Hologic (HOLX) closed at $77.22, marking a +1.62% move from the previous day.

Zacks Investment Research - 1 month ago

Hologic (HOLX), SolarEdge Technologies (SEDG) and XPO Logistics (XPO) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Other stocks mentioned: SEDG, XPO
Zacks Investment Research - 1 month ago

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

Other stocks mentioned: ABT, BDX, QDEL
Zacks Investment Research - 1 month ago

Investors continue to be optimistic about Hologic (HOLX) due to a slew of regulatory approvals and buyouts.

Zacks Investment Research - 1 month ago

In the latest trading session, Hologic (HOLX) closed at $76.48, marking a -1.76% move from the previous day.

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for January 14th

Other stocks mentioned: BJ, GM, PKI
Zacks Investment Research - 1 month ago

Is (HOLX) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 month ago

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Other stocks mentioned: ABT, BDX, DGX, LH, QDEL, QGEN
Zacks Investment Research - 1 month ago

Hologic (HOLX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research - 1 month ago

Investors are optimistic about Hologic's (HOLX) impressive preliminary results for the first quarter of fiscal 2021 and regulatory approvals.

Zacks Investment Research - 1 month ago

The uptick in Hologic's (HOLX) Diagnostics sales is likely the result of increased demand for COVID-19 testing.

Zacks Investment Research - 1 month ago

Hologic (HOLX) aims to strengthen its Diagnostics business by foraying into the oncology adjacency space via the acquisition of Biotheranostics.

Market Watch - 1 month ago

Shares of Hologic Inc. are up 5% in premarket trading Friday after the medical technology company posted preliminary revenue figures ahead of the consensus forecast. The company expects to rep...

About HOLX

Hologic develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SA... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 21, 1990
CEO
Stephen MacMillan
Employees
5,814
Stock Exchange
NASDAQ
Ticker Symbol
HOLX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for Hologic stock is "Buy." The 12-month stock price forecast is 89.08, which is an increase of 23.77% from the latest price.

Price Target
$89.08
(23.77% upside)
Analyst Consensus: Buy